BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 33430021)

  • 1. Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders.
    Catanesi M; Caioni G; Castelli V; Benedetti E; d'Angelo M; Cimini A
    Mar Drugs; 2021 Jan; 19(1):. PubMed ID: 33430021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischemic brain stroke: their molecular targets and action mechanisms.
    Choi DY; Choi H
    Arch Pharm Res; 2015 Feb; 38(2):139-70. PubMed ID: 25348867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Alzheimer's Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential.
    Kabir MT; Uddin MS; Jeandet P; Emran TB; Mitra S; Albadrani GM; Sayed AA; Abdel-Daim MM; Simal-Gandara J
    Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33925063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases.
    Javed H; Mohamed Fizur NM; Jha NK; Ashraf GM; Ojha S
    Curr Neuropharmacol; 2023; 21(6):1421-1432. PubMed ID: 36567278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
    Rahul ; Siddique YH
    CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Khezri MR; Ghasemnejad-Berenji M
    Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavonoid-based therapies in the early management of neurodegenerative diseases.
    Solanki I; Parihar P; Mansuri ML; Parihar MS
    Adv Nutr; 2015 Jan; 6(1):64-72. PubMed ID: 25593144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential implications of polyphenolic compounds in neurodegenerative diseases.
    Shi R; Gao D; Stoika R; Liu K; Sik A; Jin M
    Crit Rev Food Sci Nutr; 2024; 64(16):5491-5514. PubMed ID: 36524397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of marine compounds in the treatment of neurodegenerative diseases: a review.
    Guimarães PL; Tavares DQ; Carrião GS; Oliveira MEH; Oliveira CR
    Braz J Biol; 2023; 83():e266795. PubMed ID: 36921191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Inflammatory Activities of Marine Algae in Neurodegenerative Diseases.
    Barbalace MC; Malaguti M; Giusti L; Lucacchini A; Hrelia S; Angeloni C
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases.
    Rahman MH; Akter R; Kamal MA
    CNS Neurol Disord Drug Targets; 2021; 20(8):694-703. PubMed ID: 32703143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases.
    Barbosa M; Valentão P; Andrade PB
    Mar Drugs; 2014 Sep; 12(9):4934-72. PubMed ID: 25257784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploitation of Marine Molecules to Manage Alzheimer's Disease.
    Silva M; Seijas P; Otero P
    Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34203244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.
    Zheng H; Weiner LM; Bar-Am O; Epsztejn S; Cabantchik ZI; Warshawsky A; Youdim MB; Fridkin M
    Bioorg Med Chem; 2005 Feb; 13(3):773-83. PubMed ID: 15653345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marine Macroalgae Polyphenols as Potential Neuroprotective Antioxidants in Neurodegenerative Diseases.
    Lomartire S; Gonçalves AMM
    Mar Drugs; 2023 Apr; 21(5):. PubMed ID: 37233455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Drugs from Marine Organisms in Alzheimer's Disease.
    Russo P; Kisialiou A; Lamonaca P; Moroni R; Prinzi G; Fini M
    Mar Drugs; 2015 Dec; 14(1):5. PubMed ID: 26712769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal attenuating therapies in neurodegenerative disease.
    Mot AI; Wedd AG; Sinclair L; Brown DR; Collins SJ; Brazier MW
    Expert Rev Neurother; 2011 Dec; 11(12):1717-45. PubMed ID: 22091597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.